Results 1 to 10 of about 8,398,186 (316)

Stem cell therapy-based approaches in experimental endometriosis: a systematic review [PDF]

open access: yesReproductive Biology and Endocrinology
Background Stem cell-based therapies have emerged as a promising approach for endometriosis due to their regenerative and immunomodulatory properties. Although numerous preclinical studies have reported beneficial effects, no systematic synthesis has yet
Isabel Suárez-Carrasco   +5 more
doaj   +2 more sources

Hyperconcentrated Platelet-Rich Plasma (High-PRP) for the treatment of a non-healing ulcer of the lateral malleolus: a case report and literature review [PDF]

open access: yesCellR4, 2020
Clinical Case: A 77-year-old man with a history of hypertension (stage 2) and multiple phalanx amputations of the right hand due to Raynaud's disease, referred to our regenerative medicine Clinic for a cutaneous ulceration (of arterial origin) of the ...
M. Fernández Viña   +4 more
doaj   +1 more source

Improved outcomes of high-risk relapsed Hodgkin lymphoma patients after high-dose chemotherapy: a 15-year analysis

open access: yesHaematologica, 2021
High-dose chemotherapy and autologous stem-cell transplant (HDC/ASCT) is standard treatment for chemosensitive relapsed classical Hodgkin lymphoma, although outcomes of high-risk relapse (HRR) patients remain suboptimal.
Yago Nieto   +32 more
doaj   +1 more source

Menstrual blood-derived stromal cells: insights into their secretome in acute hypoxia conditions

open access: yesMolecular Medicine, 2023
Background Despite constant advances in regenerative medicine, the closure of chronic wounds is still challenging. Therapeutic approaches using locally administered MSCs have been considered a promising option.
María Ángeles de Pedro   +7 more
doaj   +1 more source

Semi-automated optimized method to isolate CRISPR/Cas9 edited human pluripotent stem cell clones

open access: yesStem Cell Research & Therapy, 2023
Background CRISPR/Cas9 editing systems are currently used to generate mutations in a particular gene to mimic a genetic disorder in vitro. Such “disease in a dish” models based on human pluripotent stem cells (hPSCs) offer the opportunity to have access ...
Elie Frank   +9 more
doaj   +1 more source

HLA Fully-Mismatched Sibling-Derived CD7 CAR-T Therapy Bridging to Haploidentical Hematopoietic Stem Cell Transplantation for Hepatosplenic γδ T-cell Lymphoma

open access: yesCell Transplantation, 2023
While chimeric antigen receptor (CAR)-T-cell therapy has demonstrated remarkable effectiveness in the treatment of B-cell lymphomas and leukemias, research on T-cell malignancies is still limited.
Xueer Xu   +13 more
doaj   +1 more source

Identification of very early inflammatory markers in a porcine myocardial infarction model

open access: yesBMC Veterinary Research, 2019
Background Acute myocardial infarction (AMI) is one of the most deleterious conditions leading to cardiovascular diseases and mortality. The importance of an early and accurate diagnosis assures immediate medical treatments, which are fundamental to ...
Esther López   +10 more
doaj   +1 more source

The Future of Regenerative Medicine: Cell Therapy Using Pluripotent Stem Cells and Acellular Therapies Based on Extracellular Vesicles

open access: yesCells, 2021
The rapid progress in the field of stem cell research has laid strong foundations for their use in regenerative medicine applications of injured or diseased tissues.
Margot Jarrige   +14 more
doaj   +1 more source

Identifying microRNA determinants of human myelopoiesis

open access: yesScientific Reports, 2018
Myelopoiesis involves differentiation of hematopoietic stem cells to cellular populations that are restricted in their self-renewal capacity, beginning with the common myeloid progenitor (CMP) and leading to mature cells including monocytes and ...
Megha Rajasekhar   +7 more
doaj   +1 more source

The 4-1BBζ costimulatory domain in chimeric antigen receptors enhances CD8+ T-cell functionality following T-cell receptor stimulation

open access: yesCancer Cell International, 2023
Background Chimeric antigen receptor (CAR) T-cells have revolutionized the treatment of CD19- and B-cell maturation antigen-positive haematological malignancies.
Gerard J. Chu   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy